Female patients were predominant in both cohorts, with a greater proportion in the Wegovy cohort than in the Zepbound cohort (82.65% vs
DSouza wasnt an obsessive sports fan himself, but he saw the financial value in it
Most patients require long-term or indefinite GLP-1 therapy to maintain benefits, as discontinuation typically results in weight regain and worsening metabolic parameters
To learn more, we delved into the scientific literature, looked at research from the Omada Insights Lab and interviewed Omada Health coaches Kirby Beal and Joanna Potter, and clinical specialist Jodi Moravec
De Block C, Bailey C, Wysham C, Hemmingway A, Allen SE, Peleshok J (2023) Tirzepatide for the treatment of adults with type 2 diabetes: an endocrine perspective
It may also help prevent B12 deficiency often associated with long-term use of GLP-1 medications